Global Biliary Tumor Market Size, Status and Forecast 2024-2031

Report ID: 935156 | Published Date: Sep 2024 | No. of Page: 100 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biliary Tumor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Mecine
        1.2.3 Surgery
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Biliary Tumor Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Biliary Tumor Market Perspective (2016-2027)
    2.2 Biliary Tumor Growth Trends by Regions
        2.2.1 Biliary Tumor Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Biliary Tumor Historic Market Share by Regions (2016-2021)
        2.2.3 Biliary Tumor Forecasted Market Size by Regions (2022-2027)
    2.3 Biliary Tumor Industry Dynamic
        2.3.1 Biliary Tumor Market Trends
        2.3.2 Biliary Tumor Market Drivers
        2.3.3 Biliary Tumor Market Challenges
        2.3.4 Biliary Tumor Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Biliary Tumor Players by Revenue
        3.1.1 Global Top Biliary Tumor Players by Revenue (2016-2021)
        3.1.2 Global Biliary Tumor Revenue Market Share by Players (2016-2021)
    3.2 Global Biliary Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Biliary Tumor Revenue
    3.4 Global Biliary Tumor Market Concentration Ratio
        3.4.1 Global Biliary Tumor Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biliary Tumor Revenue in 2020
    3.5 Biliary Tumor Key Players Head office and Area Served
    3.6 Key Players Biliary Tumor Product Solution and Service
    3.7 Date of Enter into Biliary Tumor Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Biliary Tumor Breakdown Data by Type
    4.1 Global Biliary Tumor Historic Market Size by Type (2016-2021)
    4.2 Global Biliary Tumor Forecasted Market Size by Type (2022-2027)

5 Biliary Tumor Breakdown Data by Application
    5.1 Global Biliary Tumor Historic Market Size by Application (2016-2021)
    5.2 Global Biliary Tumor Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Biliary Tumor Market Size (2016-2027)
    6.2 North America Biliary Tumor Market Size by Type
        6.2.1 North America Biliary Tumor Market Size by Type (2016-2021)
        6.2.2 North America Biliary Tumor Market Size by Type (2022-2027)
        6.2.3 North America Biliary Tumor Market Size by Type (2016-2027)
    6.3 North America Biliary Tumor Market Size by Application
        6.3.1 North America Biliary Tumor Market Size by Application (2016-2021)
        6.3.2 North America Biliary Tumor Market Size by Application (2022-2027)
        6.3.3 North America Biliary Tumor Market Size by Application (2016-2027)
    6.4 North America Biliary Tumor Market Size by Country
        6.4.1 North America Biliary Tumor Market Size by Country (2016-2021)
        6.4.2 North America Biliary Tumor Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Biliary Tumor Market Size (2016-2027)
    7.2 Europe Biliary Tumor Market Size by Type
        7.2.1 Europe Biliary Tumor Market Size by Type (2016-2021)
        7.2.2 Europe Biliary Tumor Market Size by Type (2022-2027)
        7.2.3 Europe Biliary Tumor Market Size by Type (2016-2027)
    7.3 Europe Biliary Tumor Market Size by Application
        7.3.1 Europe Biliary Tumor Market Size by Application (2016-2021)
        7.3.2 Europe Biliary Tumor Market Size by Application (2022-2027)
        7.3.3 Europe Biliary Tumor Market Size by Application (2016-2027)
    7.4 Europe Biliary Tumor Market Size by Country
        7.4.1 Europe Biliary Tumor Market Size by Country (2016-2021)
        7.4.2 Europe Biliary Tumor Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Biliary Tumor Market Size (2016-2027)
    8.2 Asia-Pacific Biliary Tumor Market Size by Type
        8.2.1 Asia-Pacific Biliary Tumor Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Biliary Tumor Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Biliary Tumor Market Size by Type (2016-2027)
    8.3 Asia-Pacific Biliary Tumor Market Size by Application
        8.3.1 Asia-Pacific Biliary Tumor Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Biliary Tumor Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Biliary Tumor Market Size by Application (2016-2027)
    8.4 Asia-Pacific Biliary Tumor Market Size by Region
        8.4.1 Asia-Pacific Biliary Tumor Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Biliary Tumor Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Biliary Tumor Market Size (2016-2027)
    9.2 Latin America Biliary Tumor Market Size by Type
        9.2.1 Latin America Biliary Tumor Market Size by Type (2016-2021)
        9.2.2 Latin America Biliary Tumor Market Size by Type (2022-2027)
        9.2.3 Latin America Biliary Tumor Market Size by Type (2016-2027)
    9.3 Latin America Biliary Tumor Market Size by Application
        9.3.1 Latin America Biliary Tumor Market Size by Application (2016-2021)
        9.3.2 Latin America Biliary Tumor Market Size by Application (2022-2027)
        9.3.3 Latin America Biliary Tumor Market Size by Application (2016-2027)
    9.4 Latin America Biliary Tumor Market Size by Country
        9.4.1 Latin America Biliary Tumor Market Size by Country (2016-2021)
        9.4.2 Latin America Biliary Tumor Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Biliary Tumor Market Size (2016-2027)
    10.2 Middle East & Africa Biliary Tumor Market Size by Type
        10.2.1 Middle East & Africa Biliary Tumor Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Biliary Tumor Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Biliary Tumor Market Size by Type (2016-2027)
    10.3 Middle East & Africa Biliary Tumor Market Size by Application
        10.3.1 Middle East & Africa Biliary Tumor Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Biliary Tumor Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Biliary Tumor Market Size by Application (2016-2027)
    10.4 Middle East & Africa Biliary Tumor Market Size by Country
        10.4.1 Middle East & Africa Biliary Tumor Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Biliary Tumor Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 NuCana
        11.1.1 NuCana Company Details
        11.1.2 NuCana Business Overview
        11.1.3 NuCana Biliary Tumor Introduction
        11.1.4 NuCana Revenue in Biliary Tumor Business (2016-2021)
        11.1.5 NuCana Recent Development
    11.2 NeoGenomics
        11.2.1 NeoGenomics Company Details
        11.2.2 NeoGenomics Business Overview
        11.2.3 NeoGenomics Biliary Tumor Introduction
        11.2.4 NeoGenomics Revenue in Biliary Tumor Business (2016-2021)
        11.2.5 NeoGenomics Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Biliary Tumor Introduction
        11.3.4 Novartis Revenue in Biliary Tumor Business (2016-2021)
        11.3.5 Novartis Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Details
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Biliary Tumor Introduction
        11.4.4 GlaxoSmithKline Revenue in Biliary Tumor Business (2016-2021)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 Southwest Oncology Group
        11.5.1 Southwest Oncology Group Company Details
        11.5.2 Southwest Oncology Group Business Overview
        11.5.3 Southwest Oncology Group Biliary Tumor Introduction
        11.5.4 Southwest Oncology Group Revenue in Biliary Tumor Business (2016-2021)
        11.5.5 Southwest Oncology Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Biliary Tumor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Mecine
    Table 3. Key Players of Surgery
    Table 4. Key Players of Other
    Table 5. Global Biliary Tumor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Biliary Tumor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Biliary Tumor Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Biliary Tumor Market Share by Regions (2016-2021)
    Table 9. Global Biliary Tumor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Biliary Tumor Market Share by Regions (2022-2027)
    Table 11. Biliary Tumor Market Trends
    Table 12. Biliary Tumor Market Drivers
    Table 13. Biliary Tumor Market Challenges
    Table 14. Biliary Tumor Market Restraints
    Table 15. Global Biliary Tumor Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Biliary Tumor Market Share by Players (2016-2021)
    Table 17. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tumor as of 2020)
    Table 18. Ranking of Global Top Biliary Tumor Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Biliary Tumor Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Biliary Tumor Product Solution and Service
    Table 22. Date of Enter into Biliary Tumor Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Biliary Tumor Revenue Market Share by Type (2016-2021)
    Table 26. Global Biliary Tumor Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Biliary Tumor Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Biliary Tumor Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Biliary Tumor Revenue Market Share by Application (2016-2021)
    Table 30. Global Biliary Tumor Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Biliary Tumor Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Biliary Tumor Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Biliary Tumor Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Biliary Tumor Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Biliary Tumor Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Biliary Tumor Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Biliary Tumor Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Biliary Tumor Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Biliary Tumor Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Biliary Tumor Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Biliary Tumor Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Biliary Tumor Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Biliary Tumor Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Biliary Tumor Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Biliary Tumor Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Biliary Tumor Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Biliary Tumor Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Biliary Tumor Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Biliary Tumor Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Biliary Tumor Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Biliary Tumor Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Biliary Tumor Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Biliary Tumor Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Biliary Tumor Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Biliary Tumor Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Biliary Tumor Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. NuCana Company Details
    Table 63. NuCana Business Overview
    Table 64. NuCana Biliary Tumor Product
    Table 65. NuCana Revenue in Biliary Tumor Business (2016-2021) & (US$ Million)
    Table 66. NuCana Recent Development
    Table 67. NeoGenomics Company Details
    Table 68. NeoGenomics Business Overview
    Table 69. NeoGenomics Biliary Tumor Product
    Table 70. NeoGenomics Revenue in Biliary Tumor Business (2016-2021) & (US$ Million)
    Table 71. NeoGenomics Recent Development
    Table 72. Novartis Company Details
    Table 73. Novartis Business Overview
    Table 74. Novartis Biliary Tumor Product
    Table 75. Novartis Revenue in Biliary Tumor Business (2016-2021) & (US$ Million)
    Table 76. Novartis Recent Development
    Table 77. GlaxoSmithKline Company Details
    Table 78. GlaxoSmithKline Business Overview
    Table 79. GlaxoSmithKline Biliary Tumor Product
    Table 80. GlaxoSmithKline Revenue in Biliary Tumor Business (2016-2021) & (US$ Million)
    Table 81. GlaxoSmithKline Recent Development
    Table 82. Southwest Oncology Group Company Details
    Table 83. Southwest Oncology Group Business Overview
    Table 84. Southwest Oncology Group Biliary Tumor Product
    Table 85. Southwest Oncology Group Revenue in Biliary Tumor Business (2016-2021) & (US$ Million)
    Table 86. Southwest Oncology Group Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biliary Tumor Market Share by Type: 2020 VS 2027
    Figure 2. Mecine Features
    Figure 3. Surgery Features
    Figure 4. Other Features
    Figure 5. Global Biliary Tumor Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Other Case Studies
    Figure 9. Biliary Tumor Report Years Considered
    Figure 10. Global Biliary Tumor Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Biliary Tumor Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Biliary Tumor Market Share by Regions: 2020 VS 2027
    Figure 13. Global Biliary Tumor Market Share by Regions (2022-2027)
    Figure 14. Global Biliary Tumor Market Share by Players in 2020
    Figure 15. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tumor as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Biliary Tumor Revenue in 2020
    Figure 17. Global Biliary Tumor Revenue Market Share by Type (2016-2021)
    Figure 18. Global Biliary Tumor Revenue Market Share by Type (2022-2027)
    Figure 19. North America Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Biliary Tumor Market Share by Type (2016-2027)
    Figure 21. North America Biliary Tumor Market Share by Application (2016-2027)
    Figure 22. North America Biliary Tumor Market Share by Country (2016-2027)
    Figure 23. United States Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Biliary Tumor Market Share by Type (2016-2027)
    Figure 27. Europe Biliary Tumor Market Share by Application (2016-2027)
    Figure 28. Europe Biliary Tumor Market Share by Country (2016-2027)
    Figure 29. Germany Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Biliary Tumor Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Biliary Tumor Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Biliary Tumor Market Share by Region (2016-2027)
    Figure 39. China Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Biliary Tumor Market Share by Type (2016-2027)
    Figure 47. Latin America Biliary Tumor Market Share by Application (2016-2027)
    Figure 48. Latin America Biliary Tumor Market Share by Country (2016-2027)
    Figure 49. Mexico Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Biliary Tumor Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Biliary Tumor Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Biliary Tumor Market Share by Country (2016-2027)
    Figure 55. Turkey Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. NuCana Revenue Growth Rate in Biliary Tumor Business (2016-2021)
    Figure 59. NeoGenomics Revenue Growth Rate in Biliary Tumor Business (2016-2021)
    Figure 60. Novartis Revenue Growth Rate in Biliary Tumor Business (2016-2021)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Biliary Tumor Business (2016-2021)
    Figure 62. Southwest Oncology Group Revenue Growth Rate in Biliary Tumor Business (2016-2021)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
NuCana
NeoGenomics
Novartis
GlaxoSmithKline
Southwest Oncology Group
Frequently Asked Questions
Biliary Tumor report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biliary Tumor report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biliary Tumor report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Aneurysm Therapeutics

An aneurysm is the enlargement of an artery caused by weakness in the arterial wall.
Read More